Literature DB >> 15336313

Apomorphine prevents myocardial ischemia/reperfusion-induced oxidative stress in the rat heart.

Igor Khaliulin1, Aviva Schneider, Esther Houminer, Joseph Bernard Borman, Herzl Schwalb.   

Abstract

This study examined the hypothesis that low-concentration apomorphine improves postischemic hemodynamic and mitochondrial function in the isolated rat heart model by attenuating oxidation of myocardial proteins. Control and apomorphine-treated hearts were subjected to 35 min of perfusion, 25 min of normothermic global ischemia, and 60 min of reperfusion. Apomorphine (2 microM) was introduced into the perfusate for 20 min starting from the onset of reperfusion. Apomorphine significantly (p <.05) improved postischemic hemodynamic function: work index of the heart (product of LVDP and heart rate) was twice as high in apomorphine-treated hearts compared to controls at the end of reperfusion (p <.01). After isolation of cardiac mitochondria, the respiratory control ratio (RCR) was calculated from the oxygen consumption rate of State 3 and State 4 respiration. Apomorphine significantly improved postischemic RCR (87% of preischemic value vs. 39% in control, p <.05). Using an immunoblot technique, carbonyl content of multiple unidentified myocardial proteins (mitochondrial and nonmitochondrial) was observed to be elevated after global ischemia and reperfusion. Apomorphine significantly attenuated the increased protein oxidation at the end of reperfusion. These results support the conclusion that apomorphine is capable of preventing ischemia/reperfusion-induced oxidative stress and thereby attenuating myocardial protein oxidation and preserving mitochondrial respiration function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15336313     DOI: 10.1016/j.freeradbiomed.2004.06.029

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  8 in total

1.  Estimation of restraint stress in rats using salivary amylase activity.

Authors:  Tetsuya Matsuura; Ryo Takimura; Masaki Yamaguchi; Mitsuyuki Ichinose
Journal:  J Physiol Sci       Date:  2012-07-03       Impact factor: 2.781

2.  Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation.

Authors:  Samantha J Clarke; Igor Khaliulin; Manika Das; Joanne E Parker; Kate J Heesom; Andrew P Halestrap
Journal:  Circ Res       Date:  2008-03-20       Impact factor: 17.367

Review 3.  Mitochondria and reperfusion injury of the heart--a holey death but not beyond salvation.

Authors:  Andrew P Halestrap
Journal:  J Bioenerg Biomembr       Date:  2009-04       Impact factor: 2.945

4.  6-Hydroxydopamine impairs mitochondrial function in the rat model of Parkinson's disease: respirometric, histological, and behavioral analyses.

Authors:  Andreas Kupsch; Werner Schmidt; Zemfira Gizatullina; Grazyna Debska-Vielhaber; Jürgen Voges; Frank Striggow; Patricia Panther; Herbert Schwegler; Hans-Jochen Heinze; Stefan Vielhaber; Frank Norbert Gellerich
Journal:  J Neural Transm (Vienna)       Date:  2014-03-14       Impact factor: 3.575

Review 5.  Pharmacological Insights into the Use of Apomorphine in Parkinson's Disease: Clinical Relevance.

Authors:  Manon Auffret; Sophie Drapier; Marc Vérin
Journal:  Clin Drug Investig       Date:  2018-04       Impact factor: 2.859

6.  Consecutive pharmacological activation of PKA and PKC mimics the potent cardioprotection of temperature preconditioning.

Authors:  Igor Khaliulin; Joanna E Parker; Andrew P Halestrap
Journal:  Cardiovasc Res       Date:  2010-06-16       Impact factor: 10.787

Review 7.  The role of succinate and ROS in reperfusion injury - A critical appraisal.

Authors:  Tatyana N Andrienko; Philippe Pasdois; Gonçalo C Pereira; Matthew J Ovens; Andrew P Halestrap
Journal:  J Mol Cell Cardiol       Date:  2017-07-05       Impact factor: 5.000

8.  Temperature preconditioning of isolated rat hearts--a potent cardioprotective mechanism involving a reduction in oxidative stress and inhibition of the mitochondrial permeability transition pore.

Authors:  Igor Khaliulin; Samantha J Clarke; Hua Lin; Joanna Parker; M-Saadeh Suleiman; Andrew P Halestrap
Journal:  J Physiol       Date:  2007-03-29       Impact factor: 5.182

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.